Sun Pharmaceutical Industries reports 34% rise in Q4 consolidated net profit

23 May 2024 Evaluate

Sun Pharmaceutical Industries has reported results for fourth quarter (Q4) and year ended March 31, 2024.

The company has reported net profit of Rs 867.60 crore for the quarter under review as compared to net loss of Rs 1,020.82 crore for the same quarter in the previous year. However, total income of the company decreased by 5.12% at Rs 5,758.02 crore for Q4FY24 as compared Rs 6,068.52 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 33.77% rise in its net profit at Rs 2,654.58 crore for fourth quarter ended March 31, 2024 as compared to Rs 1,984.47 crore for the same quarter in the previous year. Total income of the company increased by 11.37% at Rs 12,588.84 crore for Q4FY24 as compared Rs 11,303.95 crore for the corresponding quarter previous year.

For the year ended March 31, 2024, the company has reported 69.05% rise in its net profit at Rs 2,858.18 crore as compared to Rs 1,690.72 crore for the previous year. However, total income of the company decreased by 1.66% at Rs 20,740.93 crore for year under review as compared to Rs 21091.17 crore for year ended March 31, 2023.

For the year ended March 31, 2024, on the consolidated basis, the company has reported 13.01% rise in its net profit at Rs 9,576.38 crore as compared to Rs 8,473.58 crore for the previous year. Total income of the company increased by 11.97% at Rs 49,851.04 crore for year under review as compared to Rs 44,520.20 crore for year ended March 31, 2023.

Sun Pharma Inds. Share Price

1515.00 5.10 (0.34%)
14-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.00
Dr. Reddys Lab 6080.25
Cipla 1565.50
Zydus Lifesciences 1110.95
Lupin 1601.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.